Clinical Trials Browser

Plasmablastic Lymphoma × daratumumab × 1 year × Clear all

NCT04915248 2026-06-02

FIL_DALYA

Phase 2 Recruiting

Plasmablastic Lymphoma, Lymphoma, Recurrence

NCT04139304 2026-06-01

A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma

Phase EARLY_PHASE1 Recruiting

Plasmablastic Lymphoma